ASPIRE BIOPHARMA HOLDINGS, INC. Shareholders' Equity
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Shareholders' Equity of $11.76 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $11.76M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.87M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$6.38M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$11.47M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $11.76M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.87M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | -$6.38M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$11.47M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$9.62M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$7.95M 10-Q · filed 2026-08-13 | -$6.95M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$1.54M 10-Q · filed 2026-08-13 | -$15.57M 10-K · filed 2025-04-07 |
| 2024-12-30 | -$1.54M 10-Q/A · filed 2025-08-13 | |
| 2024-09-30 | -$774.38K 10-Q · filed 2025-11-14 | -$6.51M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$558.11K 10-Q · filed 2025-11-14 | -$5.90M 10-Q · filed 2024-08-16 |
| 2024-03-31 | -$489.75K 10-Q · filed 2025-11-14 | -$2.57M 10-Q · filed 2024-06-05 |
| 2023-12-31 | -$487.86K S-1/A · filed 2026-04-10 | -$322.11K 10-K · filed 2024-03-11 |
| 2023-12-30 | -$487.86K 10-Q · filed 2025-11-14 | |
| 2023-09-30 | -$62.95K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $261.79K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$10.26M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$9.94M 10-K · filed 2025-04-07 | |
| 2022-09-30 | -$9.62M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -$9.37M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | -$9.05M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | -$475.00 10-K · filed 2024-03-11 | |
| 2021-09-30 | $280.00 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $15.59K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $17.97K 10-Q · filed 2022-11-10 | -$17.27K 10-Q · filed 2022-05-16 |
| 2021-02-08 | $0.00 10-K · filed 2023-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |